LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.01 | 27.76 | 356 | 2662 | 0.1337 | 0.4733 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.01 | 27.76 | 3415 | 2662 | 1.2824 | 1.0770 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.71 | 27.76 | 2576 | 2877 | 0.8952 | 0.9672 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.71 | 27.76 | 2624 | 2877 | 0.9119 | 0.9726 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.71 | 27.76 | 410 | 2877 | 0.1425 | 0.4950 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 37.71 | 27.76 | 3702 | 2877 | 1.2865 | 1.0767 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.41 | 27.76 | 2746 | 3105 | 0.8842 | 0.9642 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.41 | 27.76 | 2789 | 3105 | 0.8980 | 0.9687 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.41 | 27.76 | 480 | 3105 | 0.1546 | 0.5201 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 39.41 | 27.76 | 3958 | 3105 | 1.2745 | 1.0726 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.11 | 27.76 | 2874 | 3331 | 0.8627 | 0.9577 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.11 | 27.76 | 2957 | 3331 | 0.8876 | 0.9658 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.11 | 27.76 | 552 | 3331 | 0.1657 | 0.5417 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.11 | 27.76 | 4245 | 3331 | 1.2742 | 1.0714 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.81 | 27.76 | 3123 | 3596 | 0.8684 | 0.9602 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.81 | 27.76 | 3172 | 3596 | 0.8820 | 0.9645 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.81 | 27.76 | 633 | 3596 | 0.1760 | 0.5614 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.81 | 27.76 | 4607 | 3596 | 1.2810 | 1.0718 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.52 | 27.76 | 3358 | 3884 | 0.8645 | 0.9596 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.52 | 27.76 | 3406 | 3884 | 0.8769 | 0.9635 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.52 | 27.76 | 778 | 3884 | 0.2003 | 0.5961 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.52 | 27.76 | 4986 | 3884 | 1.2836 | 1.0713 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.22 | 27.76 | 3636 | 4125 | 0.8815 | 0.9653 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.22 | 27.76 | 3677 | 4125 | 0.8914 | 0.9684 | MN20160318_Q01 | D09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.22 | 27.76 | 783 | 4125 | 0.1898 | 0.5886 | MN20160318_Q01 | K18 |